Sutro Biopharma to Participate in Three Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif., Nov. 2, 2021 /PRNewswire/ — Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and…

About the Author

has written 39063 stories on this site.

Copyright © 2010 Business and Corporate News.